ATE489942T1 - Ternäre nichtlamellare lipidzusammensetzungen - Google Patents

Ternäre nichtlamellare lipidzusammensetzungen

Info

Publication number
ATE489942T1
ATE489942T1 AT05701965T AT05701965T ATE489942T1 AT E489942 T1 ATE489942 T1 AT E489942T1 AT 05701965 T AT05701965 T AT 05701965T AT 05701965 T AT05701965 T AT 05701965T AT E489942 T1 ATE489942 T1 AT E489942T1
Authority
AT
Austria
Prior art keywords
compositions
amphiphile
nonlamellar
ternary
lipid compositions
Prior art date
Application number
AT05701965T
Other languages
English (en)
Inventor
Markus Johnsson
Fredrik Tiberg
Original Assignee
Camurus Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0401515.2A external-priority patent/GB0401515D0/en
Priority claimed from GB0407936A external-priority patent/GB0407936D0/en
Application filed by Camurus Ab filed Critical Camurus Ab
Application granted granted Critical
Publication of ATE489942T1 publication Critical patent/ATE489942T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Edible Oils And Fats (AREA)
AT05701965T 2004-01-23 2005-01-21 Ternäre nichtlamellare lipidzusammensetzungen ATE489942T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0401515.2A GB0401515D0 (en) 2004-01-23 2004-01-23 Compositions
GB0407936A GB0407936D0 (en) 2004-04-07 2004-04-07 Compositions
PCT/GB2005/000202 WO2005070394A2 (en) 2004-01-23 2005-01-21 Ternary non-lamellar lipid compositions

Publications (1)

Publication Number Publication Date
ATE489942T1 true ATE489942T1 (de) 2010-12-15

Family

ID=34809883

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05701965T ATE489942T1 (de) 2004-01-23 2005-01-21 Ternäre nichtlamellare lipidzusammensetzungen

Country Status (8)

Country Link
US (1) US8182834B2 (de)
EP (1) EP1713446B1 (de)
JP (1) JP4966018B2 (de)
AT (1) ATE489942T1 (de)
CA (1) CA2554052C (de)
DE (1) DE602005025083D1 (de)
PL (1) PL1713446T3 (de)
WO (1) WO2005070394A2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006075124A1 (en) * 2005-01-14 2006-07-20 Camurus Ab Somatostatin analogue formulations
GB0401513D0 (en) * 2004-01-23 2004-02-25 Camurus Ab Compositions
US9649382B2 (en) 2005-01-14 2017-05-16 Camurus Ab Topical bioadhesive formulations
SI1845942T1 (sl) 2005-01-14 2014-06-30 Camurus Ab Gnrh analogne formulacije
US8871712B2 (en) * 2005-01-14 2014-10-28 Camurus Ab Somatostatin analogue formulations
EP1848403B8 (de) * 2005-01-14 2010-05-19 Camurus Ab Topische bioadhäsive formulierungen
KR101245022B1 (ko) 2005-01-21 2013-03-19 카무러스 에이비 약제학적 지질 조성물
CN101217940B (zh) 2005-06-06 2013-03-27 卡穆鲁斯公司 Glp-1类似物制剂
CN103315954A (zh) 2005-07-18 2013-09-25 麻萨诸塞州洛厄尔大学 制备与使用纳米乳剂的组合物和方法
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
WO2008140594A2 (en) 2006-12-01 2008-11-20 Anterios, Inc. Peptide nanoparticles and uses therefor
CA2671447A1 (en) 2006-12-01 2008-06-12 Anterios, Inc. Amphiphilic entity nanoparticles
WO2008151022A2 (en) 2007-05-31 2008-12-11 Anterios, Inc. Nucleic acid nanoparticles and uses therefor
GB0711656D0 (en) 2007-06-15 2007-07-25 Camurus Ab Formulations
ES2382890T3 (es) * 2007-06-19 2012-06-14 Neubourg Skin Care Gmbh & Co. Kg DMS (derma membrane structure) en cremas de espuma.
GB0716385D0 (en) 2007-08-22 2007-10-03 Camurus Ab Formulations
PT104158B (pt) * 2008-08-18 2011-02-24 Univ Do Minho Aplicação da monooleína como novo lípido adjuvante em lipofecção
GB0815435D0 (en) 2008-08-22 2008-10-01 Camurus Ab Formulations
US9585959B2 (en) 2011-12-05 2017-03-07 Camurus Ab Robust controlled-release formulations
MA37672A1 (fr) 2012-05-25 2016-07-29 Camurus Ab Formulation d'agoniste des récepteurs à la somatostatine
EP3541358A1 (de) 2016-11-21 2019-09-25 Eirion Therapeutics, Inc. Transdermale verabreichung von grossen wirkstoffen
EP3938317A1 (de) 2019-03-15 2022-01-19 Saudi Arabian Oil Company Massensynthese von janus-nanomaterialien
US11422285B2 (en) 2020-06-17 2022-08-23 Saudi Arabian Oil Company Nanofluidic chips as micromodels for carbonate reservoirs
US11827850B2 (en) 2020-07-24 2023-11-28 Saudi Arabian Oil Company Enhanced oil recovery with janus nanoparticles
US11773715B2 (en) 2020-09-03 2023-10-03 Saudi Arabian Oil Company Injecting multiple tracer tag fluids into a wellbore
US11660595B2 (en) 2021-01-04 2023-05-30 Saudi Arabian Oil Company Microfluidic chip with multiple porosity regions for reservoir modeling
US11534759B2 (en) 2021-01-22 2022-12-27 Saudi Arabian Oil Company Microfluidic chip with mixed porosities for reservoir modeling
US12000278B2 (en) 2021-12-16 2024-06-04 Saudi Arabian Oil Company Determining oil and water production rates in multiple production zones from a single production well

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2133391T3 (es) 1991-10-04 1999-09-16 Gs Dev Ab Particulas, metodo para preparar dichas particulas y usos de las mismas.
SE518578C2 (sv) 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
US5885613A (en) 1994-09-30 1999-03-23 The University Of British Columbia Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
BR9806238A (pt) 1997-09-09 2005-07-12 Select Release L C Partìculas revestidas: processos de obtenção e uso
PT1079805E (pt) * 1998-04-27 2005-03-31 Opperbas Holding Bv Composicao farmaceutica compreendendo factor viii e lipossomas neutros
US6537575B1 (en) 1999-07-30 2003-03-25 The University Of Chicago Synthetic biological membrane with self organizing properties
US20020153508A1 (en) 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
US7008646B2 (en) 2001-02-20 2006-03-07 Patrick Thomas Spicer Cubic liquid crystalline compositions and methods for their preparation
US6656385B2 (en) 2001-02-21 2003-12-02 The Procter & Gamble Company Functionalized cubic liquid crystalline phase materials and methods for their preparation and use
US6936187B2 (en) 2001-02-21 2005-08-30 Matthew Lawrence Lynch Functionalized cubic liquid crystalline phase materials and methods for their preparation and use
JP5180474B2 (ja) * 2003-08-04 2013-04-10 カムルス エービー 両親媒性粒子の特性を改良する方法
GB0322033D0 (en) * 2003-09-19 2003-10-22 Camurus Ab Composition

Also Published As

Publication number Publication date
WO2005070394A2 (en) 2005-08-04
DE602005025083D1 (de) 2011-01-13
CA2554052A1 (en) 2005-08-04
WO2005070394A3 (en) 2006-01-26
JP4966018B2 (ja) 2012-07-04
CA2554052C (en) 2013-10-22
US8182834B2 (en) 2012-05-22
EP1713446A2 (de) 2006-10-25
JP2007518784A (ja) 2007-07-12
EP1713446B1 (de) 2010-12-01
US20080206317A1 (en) 2008-08-28
PL1713446T3 (pl) 2011-05-31

Similar Documents

Publication Publication Date Title
ATE489942T1 (de) Ternäre nichtlamellare lipidzusammensetzungen
Di Gianvincenzo et al. Gold nanoparticles capped with sulfate-ended ligands as anti-HIV agents
BRPI0615292A8 (pt) composições e métodos para preparação de fármacos de má solubilidade em água com estabilidade aumentada
NO20062798L (no) Anvendelse av en vannholdig dispersjon av i det minste en bio-nedbrytbar polymer inneholdende i det minste et stabiliseringsmiddel for fremstilling av en vanndig filmdannende sammensetning
DE602005025082D1 (de) Nicht-lamellare zubereitungen von dioleoyl-phosphatidyl ethanolamin und polysorbat80
CY1115825T1 (el) Φαρμακευτικες συνθεσεις που περιεχουν λεβετιρακεταμη και διαδικασια παρασκευης τους
MX2007003162A (es) Composicion farmaceutica que comprende una dispersion solida con una matriz polimerica que comprende una fase continua de polidextrosa y una fase continua de un polimero distinto de la polidextrosa.
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
WO2006013369A3 (en) Compositions forming non-lamellar dispersions
EA200800731A1 (ru) Жидкие составы гербицидов на основе сульфонилмочевины
WO2007090822A3 (de) Pharmazeutische formulierung für aerosole mit zwei oder mehr wirkstoffen und mindestens einer oberflächenaktiven substanz
WO2007022023A3 (en) Film forming spreading agents
WO2007056424A3 (en) Controlled-release emulsion compositions
MA47301B1 (fr) Inhibiteurs sélectifs de jak1
PE20070643A1 (es) Composiciones farmaceuticas que comprenden buprenorfina
EA200702638A1 (ru) Стабильная композиция (рецептура) с наночастицами ацетаминофена
WO2007038138A3 (en) Amido compounds and their use as pharmaceuticals
MX2007013065A (es) Derivados de dihidrobenzofurano y usos de los mismos.
MA31151B1 (fr) Inhibiteurs de mapk/erk kinase
NO20000466L (no) Farmasøytisk preparat for sure, lipofile forbindelser i form av en selvregulerende formulering
ATE516016T1 (de) Selbstemulgierende formulierungen von cetp- hemmern
DK2046292T3 (da) Formuleringer for benzimidazolylpyridylethere
ATE255881T1 (de) Zusammensetzungen aus unlöslichen filmbildenden polymeren und ihre verwendung
DE602005018635D1 (de) Polymerzusammensetzung
WO2009123346A3 (en) Pesticidal aqueous suspension composition

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties